







The AI company is deepening its existing partnership with the Los Alamos National Laboratory.
OpenAI Strikes Deal With US Government to Use Its AI for Nuclear Weapon Security
OpenAI has announced that the US National Laboratories will use its deeply flawed AI models to help with "nuclear security."

Introducing OpenAI
OpenAI is a non-profit artificial intelligence research company. Our goal is to advance digital intelligence in the way that is most likely to benefit humanity as a whole, unconstrained by a need to generate financial return. Since our research is free from financial obligations, we can better focus on a positive human impact.

OpenAI creates new unit with $4 billion investment to aid corporate AI push
OpenAI said on Monday it is setting up a new company with more than $4 billion in initial investment to help organizations build and deploy artificial intelligence systems, and will acquire an AI consulting firm, Tomoro, to quickly scale up the unit. After its early models saw strong resonance with consumers, OpenAI has been working aggressively to sign corporate contracts and establish a large presence in the business world where its AI will see large-scale deployment. The new firm, called OpenAI Deployment Company, will help the ChatGPT maker embed engineers specializing in frontier AI deployment into organizations that will then work closely with various teams to identify where AI can make the biggest impact, OpenAI said.
OpenAI finalises $10 billion joint venture with PE firms to deploy AI - The Economic Times
OpenAI has launched a new venture, The Deployment Company. It has secured over $4 billion from 19 investors. This company will focus on helping businesses integrate OpenAI's AI software. The venture is valued at $10 billion and will be controlled by OpenAI. This move aims to boost AI adoption across various sectors. Rival Anthropic is also exploring similar strategies.
Built to benefit everyone: our plan
A vision for the future of AI, focusing on access, safety, and shared prosperity as OpenAI works to ensure AGI benefits everyone.

OpenAI
OpenAI is an American AI focused company. Founded in December 2015, OpenAI is best known for their ChatGPT chatbot, also known for the Generative Pre-Trained Transformer...

OpenAI pushes AI agent capabilities with new developer API
New tools may help fulfill CEO's claim that agents will "join the workforce" in 2025.

OpenAI launches new initiative to help find and patch open source bugs | TechCrunch
OpenAI is using AI to help the open source community better protect itself.

OpenAI launches the OpenAI Deployment Company to help businesses build around intelligence
OpenAI launches DeployCo, a new enterprise deployment company built to help organizations bring frontier AI into production and turn it into measurable business impact.

OpenAI to release open-source model as AI economics force strategic shift
OpenAI plans to release its first open-weight AI model since 2019 as economic pressures mount from competitors like DeepSeek and Meta, marking a significant strategic reversal for the company behind ChatGPT.

OpenAI strikes Reddit deal to train its AI on your posts
Reddit’s signed AI licensing deals with Google and OpenAI.

Built to benefit everyone
OpenAI’s recapitalization strengthens mission-focused governance, expanding resources to ensure AI benefits everyone while advancing innovation responsibly.

OpenAI technical goals
OpenAI’s mission is to build safe AI, and ensure AI’s benefits are as widely and evenly distributed as possible.

OpenAI Co-founder Wanted a Doomsday Bunker in Case AGI Caused the Rapture
He seemed to be simultaneously developing supremely intelligent AI and preparing for the end times at the same time.

OpenAI to acquire Ona
OpenAI plans to acquire Ona to expand Codex with secure, persistent cloud environments, enabling long-running AI agents across enterprise workflows.

AIs can’t stop recommending nuclear strikes in war game simulations
Leading AIs from OpenAI, Anthropic and Google opted to use nuclear weapons in simulated war games in 95 per cent of cases
